These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23084281)

  • 1. Patients' experiences of adjusting insulin doses when implementing flexible intensive insulin therapy: a longitudinal, qualitative investigation.
    Lawton J; Rankin D; Cooke D; Elliott J; Amiel S; Heller S;
    Diabetes Res Clin Pract; 2012 Nov; 98(2):236-42. PubMed ID: 23084281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How and why do patients with Type 1 diabetes sustain their use of flexible intensive insulin therapy? A qualitative longitudinal investigation of patients' self-management practices following attendance at a Dose Adjustment for Normal Eating (DAFNE) course.
    Rankin D; Cooke DD; Clark M; Heller S; Elliott J; Lawton J;
    Diabet Med; 2011 May; 28(5):532-8. PubMed ID: 21244477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experiences of using blood glucose targets when following an intensive insulin regimen: a qualitative longitudinal investigation involving patients with Type 1 diabetes.
    Rankin D; Cooke DD; Heller S; Elliott J; Amiel S; Lawton J;
    Diabet Med; 2012 Aug; 29(8):1079-84. PubMed ID: 22486156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do structured education programmes work? An ethnographic investigation of the dose adjustment for normal eating (DAFNE) programme for type 1 diabetes patients in the UK.
    Lawton J; Rankin D
    Soc Sci Med; 2010 Aug; 71(3):486-493. PubMed ID: 20621746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose Adjustment for Normal Eating: a qualitative longitudinal exploration of the food and eating practices of type 1 diabetes patients converted to flexible intensive insulin therapy in the UK.
    Lawton J; Rankin D; Cooke DD; Clark M; Elliot J; Heller S;
    Diabetes Res Clin Pract; 2011 Jan; 91(1):87-93. PubMed ID: 21129802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced insulin requirements during participation in the DAFNE (dose adjustment for normal eating) structured education programme.
    Leelarathna L; Ward C; Davenport K; Donald S; Housden A; Finucane FM; Evans M
    Diabetes Res Clin Pract; 2011 May; 92(2):e34-6. PubMed ID: 21269721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supporting self-management after attending a structured education programme: a qualitative longitudinal investigation of type 1 diabetes patients' experiences and views.
    Rankin D; Cooke DD; Elliott J; Heller SR; Lawton J;
    BMC Public Health; 2012 Aug; 12():652. PubMed ID: 22891794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial.
    DAFNE Study Group
    BMJ; 2002 Oct; 325(7367):746. PubMed ID: 12364302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-treating hypoglycaemia: a longitudinal qualitative investigation of the experiences and views of people with Type 1 diabetes.
    Lawton J; Rankin D; Cooke DD; Elliott J; Amiel S; Heller S;
    Diabet Med; 2013 Feb; 30(2):209-15. PubMed ID: 22946549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Flexible intensive insulin therapy: a change in mentalities].
    Penfornis A; Chabroux S; Grimaldi A
    Rev Med Interne; 2008 Nov; 29(11):857-60. PubMed ID: 18387717
    [No Abstract]   [Full Text] [Related]  

  • 11. Reducing hypoglycaemia with insulin analogues.
    Heller S
    Int J Obes Relat Metab Disord; 2002 Sep; 26 Suppl 3():S31-6. PubMed ID: 12174321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal qualitative study examining the factors impacting on the ability of persons with T1DM to assimilate the Dose Adjustment for Normal Eating (DAFNE) principles into daily living and how these factors change over time.
    Casey D; Murphy K; Lawton J; White FF; Dineen S
    BMC Public Health; 2011 Aug; 11():672. PubMed ID: 21878104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
    Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
    Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parents' experiences of managing their child's diabetes using an insulin pump: a qualitative study.
    Rankin D; Harden J; Noyes K; Waugh N; Barnard K; Lawton J
    Diabet Med; 2015 May; 32(5):627-34. PubMed ID: 25581347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-life application and validation of flexible intensive insulin-therapy algorithms in type 1 diabetes patients.
    Franc S; Dardari D; Boucherie B; Riveline JP; Biedzinski M; Petit C; Requeda E; Leurent P; Varroud-Vial M; Hochberg G; Charpentier G
    Diabetes Metab; 2009 Dec; 35(6):463-8. PubMed ID: 19914853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-Up Support for Effective type 1 Diabetes self-management (The FUSED Model): A systematic review and meta-ethnography of the barriers, facilitators and recommendations for sustaining self-management skills after attending a structured education programme.
    Campbell F; Lawton J; Rankin D; Clowes M; Coates E; Heller S; de Zoysa N; Elliott J; Breckenridge JP
    BMC Health Serv Res; 2018 Nov; 18(1):898. PubMed ID: 30482202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of type 1 diabetes.
    Unger J
    Prim Care; 2007 Dec; 34(4):791-808, vi-vii. PubMed ID: 18061818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poorer glycaemic control in type 1 diabetes is associated with reduced self-management and poorer perceived health: a cross-sectional study.
    Ozcan S; Amiel SA; Rogers H; Choudhary P; Cox A; de Zoysa N; Hopkins D; Forbes A
    Diabetes Res Clin Pract; 2014 Oct; 106(1):35-41. PubMed ID: 25128266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of evening insulin dose in patients using the short-acting insulin analog lispro.
    Ahmed AB; Mallias J; Home PD
    Diabetes Care; 1998 Jul; 21(7):1162-6. PubMed ID: 9653613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.